MICROBIOLOGY AND INFECTIOUS DISEASES BIOLOGICAL RESEARCH REPOSITORY (MID BRR): SARS-CoV-2 VACCINE RESEARCH RELATED ACTIVITIES

微生物学和传染病生物研究知识库（MID BRR）：SARS-CoV-2 疫苗研究相关活动

• 批准号: 10619417
• 负责人: TIMOTHY STEDMAN
• 金额: $ 44.31万
• 依托单位: AMERICAN TYPE CULTURE COLLECTION
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-05-05 至 2023-05-04
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10619417
• 关键词: 2019-nCoV; Basic Science; COVID-19 vaccine; Categories; Communicable Diseases; Communities; Contracts; Emerging Communicable Diseases; Microbiology; National Institute of Allergy and Infectious Disease; Production; Reagent; Research; Resources; Vaccine Research; Vaccines; biological research; pathogen; preservation; priority pathogen; product development; repository; research and development

This contract provides unique and quality-assured infectious reagents and resources to the scientific community for use in basic research and product development. The scope of this contract includes the acquisition, authentication, production, preservation, storage, and distribution of research and reference reagents to the research community. These reagents span the pathogens in the Division of Microbiology and Infectious Diseases portfolio, and include the National Institutes of Allergy and Infectious Disease (NIAID) Category A, B and C Priority Pathogens and emerging infectious diseases.

该合同为科学界提供独特且有质量保证的感染试剂和资源，用于基础研究和产品开发。本合同的范围包括研究和参考试剂的获取、认证、生产、保存、储存以及向研究界的分发。这些试剂涵盖微生物学和传染病部门的病原体，包括美国国家过敏和传染病研究所 (NIAID) A、B 和 C 类优先病原体以及新出现的传染病。